UBS Group »

Nrx Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Nrx Pharmaceuticals (NRXP) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Nrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Nrx Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nrx Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.8k 17k 0.47
2023-12-31 $22k 47k 0.46
2023-09-30 $314 1.2k 0.26
2023-06-30 $1.3k 2.8k 0.48
2023-03-31 $12k 19k 0.66
2022-12-31 $433 390 1.11
2022-06-30 $10k 17k 0.60
2022-03-31 $11k 4.5k 2.43
2021-12-31 $53k 12k 4.52
2021-06-30 $97k 8.4k 11.57